Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Fund of hedge funds group FRM comments on risk averse Fed

Tuesday, October 08, 2013

Beverly Chandler, Opalesque London:

FRM, Man Group’s $16.7bn fund of hedge funds business, has published its Early Bird notes on September admitting that, in contrast to their prediction, the Federal Reserve continued with monetary stimulus. "We are now confronted by a Fed that is likely to be more risk averse and for longer than we previously thought. It is more than possible that the price for the short term status quo is a more disorderly exit in the future; but for now there are more pressing concerns" the firm writes.

September saw large inflows into fixed rate products, the fourth largest weekly flow on record with $3.1bn, with significant cash still to be invested. FRM believes that emerging market assets were perhaps the clearest beneficiaries of the non-taper. "Though the fundamental problems with the balance of payments in several large emerging market countries remains, the short term pressure has at least somewhat abated. It was notable that following the meeting, currencies of those countries that have been most impacted by outflows were stronger against the USD, a reversal of the moves seen since the 'taper talk’ began. Across the board emerging market equities were stronger over the month, helped not only by the continuing liquidity, but also by a constructive set of data releases from China."

Despite all the good news, and relatively heavy volumes, FRM notes that the US market is no high......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for